
Our Opportunities
Explore Investment Opportunities with Us
Empowering Our Clients for Success
At Troy Groups, we understand that our success is built on the success of our clients—both internal and external. We strive to foster a supportive environment for our internal teams while also providing exceptional service to our external partners. If you’re interested in learning how we can work together and create lasting value, don’t hesitate to reach out. Your success is our priority.

External Clients
.png)
A28
A28 Therapeutics – Redefining Cancer Treatment
A first-in-class, targeted oncolytic peptide therapy for liver-related cancers.
● 69% objective response in preclinical liver metastasis models
● Non-toxic, systemically safe across 27 studies
● Peak annual revenue potential: $3B+
Why It Matters: A28 targets one of the deadliest unmet needs in oncology with
breakthrough science.
Contact: msalih@thetroygroups.com
.png)
Bay Capital (Fund of Funds)
Bay Capital – Diversified Access to U.S. Small Business Growthwww.baycapllc.com
A fund of funds investing in SBA-backed SBICs targeting U.S. small businesses.
● Investing in 200–300 businesses via 10–20 SBIC funds
● Mezzanine debt strategy with equity upside
● Government-backed, risk-mitigated exposure
Why It Matters: Small businesses power the U.S. economy, but get <8% of capital. Bay
Capital changes that.
Contact: akshays@thetroygroups.com
.png)
Cognitive Creators
Cognitive Creators

Delta Capital
Delta Capital Fund III – Deep-Tech Growth Equity
A top-decile VC platform focused on semiconductors, AI, and medical tech.
● $900M AUM with 50+ successful semiconductor deals
● Focused on U.S. and China expansion opportunities
● Past performance: 2.3–3.4x gross returns
Why It Matters: China leads global semiconductor demand. Delta is the bridge for global
tech scale.
Contact: msalih@thetroygroups.com

NasaClip
NasaClip – The Band-Aid® for Nosebleeds
A simple, reusable, FDA-registered device that treats nosebleeds fast — no doctor needed.
● Trusted by ER physicians
● Available on Amazon & hospitals nationwide
● Targeting a $5B+ market across healthcare & consumer segments
● 16% quarterly growth since launch
Why It Matters: 60% of people experience nosebleeds. NasaClip is positioned to become a
household essential.
Contact: msalih@thetroygroups.com | akshays@thetroygroups.com
%20(2).png)
StorJ
Storj – Decentralized Cloud Infrastructure
Say goodbye to AWS lock-in. Storj offers a sovereign, scalable, and cost-effective cloud
alternative.
● 20,000+ node operators in 100+ countries
● Up to 80% cheaper and faster than AWS for large file transfers
● Ideal for AI, media, and healthcare
● $12M ARR and 7.1x YoY growth
Why It Matters: As demand for secure, decentralized computing rises, Storj leads the
charge.
Contact: msalih@thetroygroups.com

Venture Friends
VentureFriends – Early-Stage VC from Europe’s Edges
Investing in overlooked founders in FinTech, PropTech, B2B SaaS, and Marketplaces across
Europe.
● Proven returns: VF1 – 6.1x MOIC | VF2 – 3.1x | VF3 – 1.8x
● Portfolio: Blueground ($1B+), Huspy, FlexCar
Why It Matters: Europe’s untapped markets are producing breakout global startups. VF is
their first call.
Contact: msalih@thetroygroups.com | rislamaj@thetroygroups.com
Troy Groups: Strategies for Your Success
-
Our strategies at Troy Groups are designed with one goal in mind: to help you achieve financial success. We utilize a mix of traditional and innovative investment approaches, ensuring your portfolio remains resilient in varying market conditions. As you journey through our site, consider how our personalized strategies can help you navigate the world of finance with confidence.
Our Valued Partners
Key Institutional & Family Office Partners

ADNOC (Abu Dhabi National Oil Company)

Dubai Investment Council

Rothschild Family Office

Parker Lloyd Family Office

PIF (Public Investment Fund - Saudi Arabia)

Internal Clients

Troy Legal Ventures
Troy Legal Ventures empowers UK law firms to pursue high-volume consumer claims on a “no win, no fee” basis—expanding access to justice while generating strong, secured returns for investors. Backed by Troy Groups and partnered with Seven Stars Legal, we focus on precedent-based claims in areas like financial misconduct and housing disrepair.
With over £22M funded across 55,000+ cases, our model combines social impact with institutional-grade investment rigour.

Mendoza Ventures
Mendoza Ventures Fund III – Diverse Tech with a Dual-Use Edge
A tech-driven VC firm investing in AI, cybersecurity, and fintech
● $40M already raised toward $100M Fund III
● Backed by Bank of America + top-tier LPs
● Co-investment access to all deals
● Led by ex-tech operators with 4 exits
Why It Matters: Tech that matters — built by experts, backed by institutions, and primed for
impact.
Contact: rislamaj@thetroygroups.com

1435 BioFrontiers
1435 BioFrontiers Fund – Biotech at the Edge of Space
Investing in early-stage biotech companies using Earth and space-based innovation to extend human healthspan.
● Space-based biotech accelerates breakthroughs in drug discovery & tissue engineering
● Biotech market projected to hit $5.7T by 2033
● Exclusive deal flow via NASA’s InSPA and top accelerators
● Focus: Seed-stage, high-impact health ventures
Why It Matters: The future of medicine is being written in orbit. 1435 is already there.
Contact: akshays@thetroygroups.com
Empowering Businesses Through Strategic Fundraising
Case Studies & Success Stories
At Troy Groups, we have successfully raisedcapital for top-tier companies across diverseindustries, leveraging our global investornetwork and exclusive roadshows.

Medu Capital
meducapital.co.za
Secured a significant portion of the $300M fundraising target. Achieved through a Middle Eastern roadshowand an exclusive investor event.

Nova Quest
novaquest.com
Raised $150M for Animal Healthcare Fund 1. Secured funding for Biotech Fund 5. Executed through a Middle Eastern roadshow &three investor events in London, Zurich, and Miami.

Saladax
saladax.com
Series B funding of $25M Facilitated drugdevelopment and distribution in Asia via our London event & Middle East roadshow.

SCV Ventures
scv.vc/portfolio
Raised $250M for Tech Fund 3. Achieved through two Middle East roadshows, withtwo more events in the pipeline.